Annual Drug Patent Expirations for VEREGEN
Veregen is a drug marketed by Fougera Pharms Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
Drug patent litigation for VEREGEN.
This drug has forty-two patent family members in twenty countries.
The generic ingredient in VEREGEN is sinecatechins. One supplier is listed for this compound. Additional details are available on the sinecatechins profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
